Fr | Ar

Dr. Adel TABCHI (EL)

Faculty of Medicine

Lecturer

(+961) 1 421 000 ext adel.tabshy@usj.edu.lb

Dr Adel Tabchi is a lecturer in the oncology department at Saint-Joseph University medical school an oncologist at Hotel-Dieu de France University Hospital

Highest degree : Medical Doctor (MD) with a Medical Oncology Fellowship Diploma - University of Texas MD Anderson Cancer Center - USA


DegreesUniversityCountryYear
MEDICAL ONCOLOGY FELLOWSHIP DIPLOMAThe University of Texas MD Anderson Cancer CenterEtats-Unis2010
RESIDENCY IN INTERNAL MEDICINE DIPLOMABoston UniversityEtats-Unis2007
MASTERS OF SCIENCE IN BIOENGINEERING DIPLOMAMASSACHUSETTS INSTITUTE OF TECHNOLOGYEtats-Unis2004
MD DiplomaAmerican University of Beirut (AUB)Lebanon2001
Bachelor of Science DiplomaAmerican University of Beirut (AUB)Lebanon1997

I teach about cancer pathophysiology. I teach about cancer Epidemiology Risk factors. I teach about Breast cancer Diagnosis Treatment.

Experience in University Teaching Outside USJCountryInstitutionStart DateEnd Date
Consultant in Medical Oncology, Head Breast Center, Professor of MedicineUnited Arab EmiratesMAYO CLINIC ABU DHABI01/10/202101/10/2022
Medical Oncology, Professor of MedicineUnited States of AmericaWashington University in St Louis, School of Medicine01/01/201301/03/2015
Medical Oncology, Faculty MemberUnited States of AmericaThe University of Texas MD ANDERSON CANCER CENTER01/07/200702/07/2011

Professional ExperienceOrganizationStart dateEnd date
Consultant in Medical Oncology, Head Breast Center, Professor of MedicineMAYO CLINIC ABU DHABI01/10/202101/10/2022
Attending Physician, Medical Oncology, Professor of MedicineWashington University in St Louis, School of Medicine01/01/201301/03/2015
Attending Physician, Medical Oncology, Faculty MemberMD ANDERSON CANCER CENTER, HOUSTON, TX01/07/200701/07/2011

Medecine and Health

I am the recipient of NIH grants to investigate pathologic processes at the molecular level in Breast cancers. I am a clinical translational researcher. I investigate Breast cancers.

Adel Tabchy, Vicente Valero, Tatiana Vidaurre, Ana Lluch, Henry Gomez, Miguel Martin, Yuan Qi, Luis Javier Barajas-Figueroa, Eduardo Souchon, Charles Coutant, Franco D Doimi, Nuhad K Ibrahim, Yun Gong, Gabriel N Hortobagyi, Kenneth R Hess, W Fraser Symmans, Lajos Pusztai. Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. Clinical Cancer Research. 2010 Nov 116(21):5351-61. Epub 2010 Sep 9.